NASDAQ · PRVA
Privia Health Group, Inc.
$22.00+$0.16 (+0.71%)
Privia Health Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.68% below the high.
Loading market information…
NASDAQ · HSTM · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
HealthStream, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
HealthStream, Inc.’s forward annual dividend is $0.14 per share, paid quarterly. The forward yield is 0.41% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
HealthStream, Inc.’s next earnings report is currently expected on Nov 2, 2026, with estimated earnings per share of $0.16. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow HealthStream, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment provides a suite of software-as-a-service (SaaS) and subscription-based tools. These comprehensive services address various aspects of healthcare staff development and management, encompassing clinical skill enhancement, talent acquisition and retention, training programs, educational resources, professional certification, scheduling logistics, competency evaluations, and performance reviews. Additionally, this segment offers support through implementation and account management. Specific applications under this umbrella cover learning platforms, performance assessment, competency tracking, disclosure management, clinical skill evaluation, simulation-based learning, quality assurance, and sector-specific training. Complementing this, the Provider Solutions segment focuses on administrative and operational needs. It includes VerityStream, an enterprise platform designed to optimize the experience for healthcare providers across diverse settings such as ambulatory surgery centers, urgent care clinics, medical groups, and other facilities. Furthermore, HealthStream offers EchoCredentialing and MSOW platforms to streamline the credentialing, enrollment, and privileging processes for medical staff in hospitals. EchoOneApp facilitates provider enrollment for medical groups. Other key offerings comprise CredentialMyDoc, a SaaS solution for credentialing and enrollment for medical groups and surgery centers; CredentialStream, another SaaS-based platform for provider credentialing, privileging, and enrollment; and NurseGrid Mobile, a dedicated application for nurse managers. These diverse solutions are marketed directly to a broad spectrum of healthcare entities, including private, non-profit, and governmental organizations, as well as pharmaceutical and medical device manufacturers.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 5, 2025 | $0.14-12.5% vs estimate | $73.49M-2.25% vs estimate |
|---|
| Q4 2024 | Feb 24, 2025 | $0.16+23.08% vs estimate | $74.24M+0.94% vs estimate |
|---|
| Q3 2024 | Oct 21, 2024 | $0.19+46.15% vs estimate | $73.10M-0.61% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
16 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $27.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$22.00+$0.16 (+0.71%)
Privia Health Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.68% below the high.
$12.53+$0.16 (+1.29%)
Phreesia, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.31% below the high.
$23.49+$0.02 (+0.09%)
NRC Health’s quoted price sits in the upper half of its reported 52-week range, 3.73% below the high.
$4.25-$0.08 (-1.85%)
Evolent Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 40.14% below the high.
$14.98+$0.86 (+6.09%)
American Well Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
$1.79-$0.01 (-0.56%)
Health Catalyst, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.88% below the high.
$1.12-$0.02 (-1.75%)
Definitive Healthcare Corp.’s quoted price sits in the lower half of its reported 52-week range, 62.67% below the high.
$2.32+$0.09 (+4.04%)
LifeMD, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.9% below the high.
